Conditions: Glaucoma Open Angle or Ocular Hypertension
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 258
Healthy volunteers: no

Brief summary:
The main purpose of this prospective study is to demonstrate the therapeutic equivalence of topical brinzolamide dosed three times daily compared with AzoptTM (brinzolamide ophthalmic suspension 1%) dosed three times daily in IOP reduction in patients with POAG or OH.

Detailed description:

Arms:
arm 1: Ophthalmic suspension arm 2: ophthalmic suspension

Interventions: intervention 1: brinzolamide 1% ophthalmic suspension intervention 2: Azopt 1%
Intervention descriptions: intervention 1: brinzolamide 1% ophthalmic suspension intervention 2: Azopt 1%, RLD

Protocol document: